HOME › DRUGS › GUSPERIMUS
ACTIVE SUBSTANCE / INN

GUSPERIMUS

Brand name(s): Spanidin
EMA LISTED
APPLICATION WITHDRAWN
Wegener Granulomatosis
ACTIVE SUBSTANCE
Gusperimus
REGULATORS
EMA
SPONSORS / MAH
Euro Nippon Kayaku GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SpanidinEuro Nippon Kayaku GmbHApplication withdrawnWegener Granulomatosis

FULL INTELLIGENCE ON GUSPERIMUS

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →